Minerva Neurosciences (NERV) Leases (2019 - 2021)

Minerva Neurosciences posted quarterly Leases of $14939.0 for Q2 2021, down 91.88% year-on-year from $184020.0 in Q2 2020, and down 74.66% on a QoQ basis from $58953.0 in Q1 2021.

Minerva Neurosciences (NERV) has 3 years of Leases data on file, last reported at $14939.0 in Q2 2021.

  • For the quarter ending Q2 2021, Leases fell 91.88% year-over-year to $14939.0; the trailing twelve-month figure through Jun 2021 stood at $14939.0 (down 91.88% YoY), and the FY2020 full-year result was $101786.0, down 61.14% from the prior year.
  • Leases for Q2 2021 stood at $14939.0, down from $58953.0 in the prior quarter.
  • Across five years, Leases topped out at $371370.0 in Q1 2019 and bottomed at $14939.0 in Q2 2021.
  • The 3-year median for Leases is $203761.5 (2020), against an average of $199522.9.
  • The widest annual swing landed in 2020, when Leases tumbled 39.82%; it then plunged 91.88% in 2021.
  • A 3-year view of Leases shows it stood at $261952.0 in 2019, then slumped by 61.14% to $101786.0 in 2020, then plunged by 85.32% to $14939.0 in 2021.
  • The last three Leases figures came in at $14939.0 (Q2 2021), $58953.0 (Q1 2021), and $101786.0 (Q4 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Minerva Neurosciences 215.11 Mn 215.11 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 14,939.00
Mar 31, 2021 58,953.00
Dec 31, 2020 101,786.00
Sep 30, 2020 143,465.00
Jun 30, 2020 184,020.00
Mar 31, 2020 223,503.00
Dec 31, 2019 261,952.00
Sep 30, 2019 299,392.00
Jun 30, 2019 335,849.00
Mar 31, 2019 371,370.00